Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

LAITH POTROUS MD PLLC

NPI: 1861155772 · STERLING HEIGHTS, MI 48310 · Family Medicine Physician · NPI assigned 10/18/2021

$3.98M
Total Medicaid Paid
117,563
Total Claims
100,037
Beneficiaries
52
Codes Billed
2022-02
First Month
2024-12
Last Month

Provider Details

Authorized OfficialPOTROUS, LAITH (OWNER)
NPI Enumeration Date10/18/2021

Related Entities

Other providers sharing the same authorized official: POTROUS, LAITH

ProviderCityStateTotal Paid
FAMILY CARE URGENT CARE PLLC STERLING HEIGHTS MI $23K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2022 19,450 $714K
2023 41,988 $1.53M
2024 56,125 $1.74M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 31,416 24,179 $1.94M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 12,208 10,735 $1.01M
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 5,357 5,344 $404K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 1,488 1,474 $161K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 4,934 4,451 $128K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 10,814 9,378 $111K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 3,779 1,976 $51K
71046 Radiologic examination, chest; 2 views 1,627 1,513 $26K
99401 1,425 1,275 $26K
72100 1,026 1,014 $21K
36415 Collection of venous blood by venipuncture 6,089 5,750 $19K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 943 921 $13K
72040 463 453 $10K
J1885 Injection, ketorolac tromethamine, per 15 mg 6,531 5,825 $7K
73560 367 321 $6K
81003 3,961 3,611 $6K
93000 894 878 $6K
99000 6,061 5,524 $4K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 587 544 $3K
73620 166 158 $3K
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 2,049 1,984 $2K
73120 127 121 $2K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 537 514 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 126 125 $2K
69210 80 54 $2K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 290 265 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg 1,262 1,039 $1K
20610 45 39 $1K
99402 23 21 $948.39
99195 17 15 $916.95
J1100 Injection, dexamethasone sodium phosphate, 1 mg 3,027 2,748 $904.04
78268 15 15 $875.59
96160 442 426 $677.30
16020 17 15 $658.30
90686 50 50 $625.80
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 14 14 $594.86
90756 14 14 $359.34
82962 207 195 $343.34
J2919 Injection, methylprednisolone sodium succinate, 5 mg 178 165 $336.71
J2405 Injection, ondansetron hydrochloride, per 1 mg 835 810 $286.44
73100 14 13 $284.96
99407 15 13 $269.91
73020 19 19 $222.71
81002 69 65 $178.56
81025 24 24 $172.83
J1200 Injection, diphenhydramine hcl, up to 50 mg 175 155 $152.31
J1030 Injection, methylprednisolone acetate, 40 mg 12 12 $103.77
87807 13 13 $76.82
1111F 282 266 $0.01
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 6,104 4,493 $0.00
G8420 Bmi is documented within normal parameters and no follow-up plan is required 1,278 948 $0.00
36410 67 63 $0.00